Table 1.
Demographic and clinical characteristics of IBD patients with or without psoriasis
| Variable | IBD psoriasis (n = 131) | IBD only (n = 700) | p value |
|---|---|---|---|
|
| |||
| Age (yrs) | 39 (32,51) | 44 (34,58) | 0.005 |
| Gender | < 0.001 | ||
| Male | 47/131 (36%) | 365/700 (52%) | |
| Female | 84/131 (64%) | 335/700 (48%) | |
| Race | 0.024 | ||
| African American | 13/131 (10%) | 64/700 (9.3%) | |
| Asian | 1/131 (0.8%) | 6/700 (0.9%) | |
| Caucasian | 108/131 (84%) | 615/700 (89%) | |
| Other | 6/131 (4.6%) | 6/700 (0.9%) | |
| Unknown | 3/131 (2.3%) | 9/700 (1.3%) | |
| History of IBD-related surgery | 75 (57%) | 420 (60%) | 0.6 |
| Therapy class | 0.037 | ||
| Anti-TNF | 81/131 (62%) | 457/700 (65%) | |
| Anti-IL-12/23 | 22/131 (17%) | 83/700 (12%) | |
| Anti-Integrin | 10/131 (7.6%) | 96/700 (14%) | |
| JAK inhibitor | 7/131 (5.3%) | 15/700 (2.1%) | |
| Anti-TNF + IM | 11/131 (8.4%) | 49/700 (7%) | |